DS
VTAE

David Shaw’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

David Shaw’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-36,926
Closed -$245K – 3669
2016
Q1 		$245K Sell
36,926
-166,536
-82% -$1.51M ﹤0.01% 3108
2015
Q4 		$3.68M Buy
203,462
+82,539
+68% +$1.14M 0.01% 1655
2015
Q3 		$1.33M Buy
+120,923
New +$1.28M ﹤0.01% 2406

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

David Shaw's VTAE Position: Q2 2016 in Review

David Shaw sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2016, closing a stake of 36,926 shares — an estimated $245K sold.

David Shaw first reported a position in VTAE in Q3 2015 and held it in 3 quarters. The position peaked at $3.68M in Q4 2015. 71 funds tracked by Wall St. Rank hold VTAE as of Q2 2016.

  • David Shaw reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2016 after selling out during the quarter.
  • David Shaw sold 36,926 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2016, an estimated $245K.
  • David Shaw first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2015 and held it in 3 quarters.
  • David Shaw's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.68M in Q4 2015.
  • 71 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.